SELLAS Life Sciences (SLS) Inventory (2013 - 2015)

SELLAS Life Sciences (SLS) reported Inventory of $1.4 million for Q2 2015, up 229.33% year-over-year from $433000.0 in Q2 2014, and up 123.86% on a QoQ basis from $637000.0 in Q1 2015.

SELLAS Life Sciences (SLS) has 3 years of Inventory data on file, last reported at $1.4 million in Q2 2015.

  • Quarterly Inventory rose 229.33% year-over-year to $1.4 million in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $1.4 million (up 229.33% YoY) and the FY2014 annual result came in at $655000.0, up 69.69% from the prior year.
  • Inventory improved to $1.4 million in Q2 2015 per SLS's latest filing, from $637000.0 in the prior quarter.
  • Across five years, Inventory topped out at $1.4 million in Q2 2015 and bottomed at $352000.0 in Q2 2013.
  • The 3-year median for Inventory is $433000.0 (2014), against an average of $569111.1.
  • The widest annual swing landed in 2014, when Inventory rose 5.88%; it then surged 229.33% in 2015.
  • Tracing SLS's Inventory over 3 years: stood at $386000.0 in 2013, then surged by 69.69% to $655000.0 in 2014, then surged by 117.71% to $1.4 million in 2015.
  • Per Business Quant, the three latest SLS Inventory figures stand at $1.4 million (Q2 2015), $637000.0 (Q1 2015), and $655000.0 (Q4 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 32.00 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.77 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.10 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 84.03 Mn
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2015 1.43 Mn
Mar 31, 2015 637,000.00
Dec 31, 2014 655,000.00
Sep 30, 2014 450,000.00
Jun 30, 2014 433,000.00
Mar 31, 2014 358,000.00
Dec 31, 2013 386,000.00
Sep 30, 2013 425,000.00
Jun 30, 2013 352,000.00